ID   253J-Lung-IV
AC   CVCL_6G34
SY   253J-lung-IV; 253J-Lung
DR   Wikidata; Q54583657
RX   PubMed=7658585;
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Doubling time: 41 +- 4 hours (PubMed=7658585).
CC   Derived from site: Metastatic; Retroperitoneal lymph node; UBERON=UBERON_0035371.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7935 ! 253J
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
RX   PubMed=7658585; DOI=10.1016/S0022-5347(01)66923-4;
RA   Dinney C.P.N., Fishbeck R., Singh R.K., Eve B., Pathak S., Brown N.,
RA   Xie B., Fan D., Bucana C.D., Fidler I.J., Killion J.J.;
RT   "Isolation and characterization of metastatic variants from human
RT   transitional cell carcinoma passaged by orthotopic implantation in
RT   athymic nude mice.";
RL   J. Urol. 154:1532-1538(1995).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//